Gene: RBM12B
Official Full Name: RNA binding motif protein 12Bprovided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be involved in regulation of RNA splicing. Predicted to be part of ribonucleoprotein complex. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14676 | RBM12B Knockout cell line (HeLa) | Human | RBM12B | 1:3~1:6 | Negative | Online Inquiry |
KO14677 | RBM12B Knockout cell line (HCT 116) | Human | RBM12B | 1:2~1:4 | Negative | Online Inquiry |
KO14678 | RBM12B Knockout cell line (HEK293) | Human | RBM12B | 1:3~1:6 | Negative | Online Inquiry |
KO14679 | RBM12B Knockout cell line (A549) | Human | RBM12B | 1:3~1:4 | Negative | Online Inquiry |
RBM12B Gene Knockout Cell Lines are specially engineered cellular models designed to provide researchers with the ability to study the role and function of the RBM12B gene in various biological processes. These cell lines have been created through the use of CRISPR-Cas9 technology, enabling precise deletion of the RBM12B gene, which is implicated in key cellular functions such as RNA binding, gene expression regulation, and splicing. By utilizing these knockout lines, scientists can investigate the phenotypic implications of RBM12B deficiency, including impacts on cellular growth, differentiation, and response to stressors.
The primary function of RBM12B Gene Knockout Cell Lines is to act as valuable experimental tools for elucidating the molecular pathways and mechanisms influenced by the RBM12B gene. The knockout of this essential gene allows for in-depth studies of gene interactions, signaling pathways, and potential contributions to disease states, particularly in the context of developmental biology and cancer research. These cell lines can be used as a robust platform for high-throughput screening of drugs and compounds, allowing researchers to evaluate therapeutic targets with unprecedented specificity.
In terms of scientific importance, RBM12B Gene Knockout Cell Lines have numerous applications in both research and clinical settings. They offer unique insights into gene function and its association with human diseases, bridges crucial gaps in understanding pathophysiological processes, and serve as a basis for developing targeted therapies. The knockout approach also solidifies the validation of gene function, allowing for the exploration of genetic contributions to various disorders.
Compared to alternative models, RBM12B Gene Knockout Cell Lines offer several advantages: they provide a high degree of specificity in targeting the RBM12B gene, maintain relevant physiological characteristics of native cells, and facilitate reproducible experimental results that are vital for the advancement of molecular biology research. Additionally, these cell lines are compatible with a wide range of assays and techniques, making them versatile tools in any research laboratory.
Ultimately, the value of RBM12B Gene Knockout Cell Lines lies in their ability to enhance our understanding of gene function in health and disease, leading to potential breakthroughs in therapeutic strategies. With a deep commitment to scientific innovation and quality, our company specializes in the development and provision of advanced biological tools and resources, supporting researchers and clinicians in their pursuit of discovery and application in biotechnology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.